do you need prescription for bpc 157 What we know about 'research only' peptides? Q&A with expert Stuart Phillips Peptide Therapy in Austin, TX

In the SURMOUNT-1 trial with 2,539 participants, patients taking 15 mg tirzepatide weekly (combined with diet and exercise) lost an average of 20.9% of their body weight over 72 weeks

Same intervention, different internal conditions completely different result

Do not expose to repeated freezethaw cycles

(7) BPC-157 Peptide and Tissue Damage A study was conducted to understand the extent of the angiogenic potential of the peptide beyond local wounds, ligaments, and GI tract wounds and to study its action on multiple gastrointestinal lesions on the pancreas, liver injuries, heart damage, endothelium damage, and blood pressure